86941-00-6

Basic information

• Product Name: (1R,3s,5S)-Methyl 6-oxabicyclo[3.1.0]hexane-3-carboxylate
• Synonyms: (1R,3s,5S)-Methyl 6-oxabicyclo[3.1.0]hexane-3-carboxylate;METHYL CIS-6-OXABICYCLO[3.1.0]HEXANE-3-CARBOXYLATE
• CAS NO: 86941-00-6
• Molecular Formula: C₇H₁₀O₃
• Molecular Weight: 142.1525
• Mol File: 86941-00-6.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (1R,3s,5S)-Methyl 6-oxabicyclo[3.1.0]hexane-3-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (1R,3s,5S)-Methyl 6-oxabicyclo[3.1.0]hexane-3-carboxylate(86941-00-6)
• EPA Substance Registry System: (1R,3s,5S)-Methyl 6-oxabicyclo[3.1.0]hexane-3-carboxylate(86941-00-6)

Safety Data

• Hazardous Substances Data: 86941-00-6(Hazardous Substances Data)

Usage

General Description

The chemical compound "(1R,3s,5S)-Methyl 6-oxabicyclo[3.1.0]hexane-3-carboxylate" is a bicyclic ester with a unique structure. It is a derivative of 6-oxabicyclo[3.1.0]hexane, which is a bicyclic compound containing an oxygen atom bridging two carbon atoms. The compound has a methyl group attached to the carbon in the 1R position, and a carboxylic ester group attached to the carbon in the 3 position. (1R,3s,5S)-Methyl 6-oxabicyclo[3.1.0]hexane-3-carboxylate has potential applications in medicinal chemistry and organic synthesis due to its interesting structure and potential reactivity. However, further research is needed to fully understand its properties and potential uses.

Upstream product

• 58101-60-3 methyl cyclopent-3-ene-1-carboxylate 

Downstream Products

• 366006-09-9 methyl (3R,4R)-3,4-dihydroxycyclopentanecarboxylate 
• 174292-58-1 methyl (1S,3S)-3-hydroxycyclopentanecarboxylate 

Relevant articles and documents

3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR

The present invention is directed to pyrazol-4-yl-pyridine compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

NITROOXY CYCLOALKANE DERIVATIVES

A compound having the structure wherein Y is selected from the group consisting of –C(O)OR2, -C(O)NHR8, -C(CH2)1-2OR3, OH, and or a pharmaceutically acceptable salt thereof, and methods of using the compounds for treating hypertension.

Synthesis of carbocyclic phosphononucleosides

Syntheses of carbocyclic analogs of phosphononucleosides are described by two different methods (introduction of the heterocycle under Mitsunobu conditions or build-up of the base around a cyclopentylamine moiety).